Awareness and knowledge of the Good Samaritan Drug Overdose Act among people at risk of witnessing an overdose in British Columbia, Canada: a multi-methods cross sectional study.


Journal

Substance abuse treatment, prevention, and policy
ISSN: 1747-597X
Titre abrégé: Subst Abuse Treat Prev Policy
Pays: England
ID NLM: 101258060

Informations de publication

Date de publication:
25 05 2022
Historique:
accepted: 11 05 2022
entrez: 25 5 2022
pubmed: 26 5 2022
medline: 28 5 2022
Statut: epublish

Résumé

Bystanders to drug overdoses often avoid or delay calling 9-1-1 and cite fear of police involvement as a main reason. In 2017, the Good Samaritan Drug Overdose Act (GSDOA) was enacted by the Canadian government to provide people present at an overdose with legal protection from charges for simple drug possession, and conditions stemming from simple possession. Few studies have taken a multi-methods approach to evaluating the GSDOA. We used quantitative surveys and qualitative interviews to explore awareness, understanding, and perceptions of the GSDOA in people at risk of witnessing an overdose. Quantitative cross-sectional surveys and qualitative telephone interviews were conducted with adults and youth at risk of witnessing an overdose across British Columbia. Cross-sectional survey participants were recruited at 19 Take Home Naloxone sites and online through Foundry. Multivariable logistic regression models were constructed hierarchically to determine factors associated with GSDOA awareness. Telephone interview participants were recruited by research assistants with lived/living experience of substance use. Deductive and inductive thematic analyses were conducted to identify major themes. Overall, 52.7% (n = 296) of the quantitative study sample (N = 453) reported being aware of the GSDOA. In multivariable analysis, cellphone possession (adjusted odds ratio [AOR] = 2.19; 95% confidence interval [CI] 1.36, 3.54) and having recently witnessed an opioid overdose (AOR = 2.34; 95% CI 1.45, 3.80) were positively associated with GSDOA awareness. Young adults (25 - 34 years) were more likely to be aware of the Act (AOR = 2.10; 95% CI 1.11, 3.98) compared to youth (16-24 years). Qualitative interviews (N = 42) revealed that many overestimated the protections offered by the GSDOA. To increase awareness and knowledge of the Act among youth, participants recommended adding the GSDOA to school curricula and using social media. Word of mouth was suggested to reach adults. Both awareness and knowledge of the GSDOA remain low in BC, with many overestimating the protections the Act offers. Dissemination efforts should be led by people with lived/living experience and should target those with limited awareness and understanding of the Act as misunderstandings can erode trust in law enforcement and harm reduction policy.

Identifiants

pubmed: 35614474
doi: 10.1186/s13011-022-00472-4
pii: 10.1186/s13011-022-00472-4
pmc: PMC9131579
doi:

Substances chimiques

Narcotic Antagonists 0
Naloxone 36B82AMQ7N

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

42

Informations de copyright

© 2022. The Author(s).

Références

Public Health Rep. 2020 May/Jun;135(3):393-400
pubmed: 32264789
J Addict Med. 2014 May-Jun;8(3):153-63
pubmed: 24874759
BMC Health Serv Res. 2018 Dec 17;18(1):971
pubmed: 30558595
Addiction. 2019 Sep;114(9):1602-1613
pubmed: 31166621
Int J Prison Health. 2021 Aug 25;ahead-of-print(ahead-of-print):
pubmed: 34633774
Int J Methods Psychiatr Res. 2011 Mar;20(1):40-9
pubmed: 21499542
PLoS One. 2019 Dec 5;14(12):e0225548
pubmed: 31805082
Front Public Health. 2017 Aug 07;5:194
pubmed: 28824900
Milbank Q. 2003;81(2):221-48, 171-2
pubmed: 12841049
Subst Abus. 2018;39(2):233-238
pubmed: 28972445
Health Serv Res. 2019 Apr;54(2):407-416
pubmed: 30740691
Drug Alcohol Depend. 2016 May 1;162:211-8
pubmed: 27020323
Int J Drug Policy. 2017 Oct;48:115-124
pubmed: 28734745
Addiction. 1996 Mar;91(3):413-7
pubmed: 8867203
Int J Drug Policy. 2017 Dec;50:82-89
pubmed: 29040841
Addict Behav. 2018 Nov;86:90-95
pubmed: 29610001
Harm Reduct J. 2018 Apr 6;15(1):18
pubmed: 29625609
Int J Drug Policy. 2021 Nov;97:103410
pubmed: 34438275
Drug Alcohol Depend. 2012 Jan 1;120(1-3):168-73
pubmed: 21839588
J Addict Dis. 2007;26(4):63-8
pubmed: 18032233
Harm Reduct J. 2021 Aug 26;18(1):91
pubmed: 34446026
Harm Reduct J. 2016 Jul 26;13(1):24
pubmed: 27455957
BMJ Open. 2019 Oct 28;9(10):e030046
pubmed: 31662368
Can Anaesth Soc J. 1969 Mar;16(2):151-61
pubmed: 5773493
Int J Drug Policy. 2022 Jul;105:103714
pubmed: 35561485
Res Nurs Health. 2008 Aug;31(4):391-8
pubmed: 18203128
J Urban Health. 2013 Dec;90(6):1102-11
pubmed: 23900788
Am J Public Health. 2015 Nov;105(11):e29-49
pubmed: 26451760
Int J Drug Policy. 2020 Feb;76:102623
pubmed: 31865117
Drug Alcohol Depend. 2018 Sep 1;190:6-8
pubmed: 29960202
Addiction. 2002 Dec;97(12):1511-6
pubmed: 12472634
Int J Drug Policy. 2019 Sep;71:157-163
pubmed: 30691944
Drug Alcohol Depend. 2016 Aug 01;165:22-8
pubmed: 27262898
Int J Drug Policy. 2016 Jan;27:178-81
pubmed: 26644025
Addiction. 2005 Mar;100(3):397-404
pubmed: 15733253
Int J Drug Policy. 2015 Dec;26(12):1251-7
pubmed: 26205676
Harm Reduct J. 2021 Feb 11;18(1):18
pubmed: 33573661
Int J Drug Policy. 2015 Jan;26(1):84-91
pubmed: 25151334
Health Educ Behav. 2021 Mar 4;:1090198121999303
pubmed: 33660550
Harm Reduct J. 2017 Jun 5;14(1):31
pubmed: 28583136
Subst Abus. 2020;41(3):301-306
pubmed: 31644397
Int J Drug Policy. 2021 Apr;90:102773
pubmed: 32467017
J Addict Med. 2016 Sep-Oct;10(5):300-8
pubmed: 27261669
Drugs (Abingdon Engl). 2021;28(4):328-339
pubmed: 34321719
Ann Transl Med. 2016 Mar;4(6):111
pubmed: 27127764
BMJ Open. 2016 Jun 21;6(6):e011224
pubmed: 27329442

Auteurs

Emma Ackermann (E)

School of Population and Public Health, University of British Columbia, 2206 E Mall, Vancouver, BC, V6T 1Z8, Canada.

Bradley Kievit (B)

School of Population and Public Health, University of British Columbia, 2206 E Mall, Vancouver, BC, V6T 1Z8, Canada.

Jessica Xavier (J)

British Columbia Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.

Skye Barbic (S)

Occupational Science and Occupational Therapy, University of British Columbia, T325 2211 Wesbrook Mall, Vancouver, BC, V6T 2A1, Canada.
Providence Health Care Research Institute, 10th Floor 1190 Hornby St, Vancouver, BC, V6Z 2K5, Canada.
Center for Health Evaluation and Outcome Sciences, St. Paul's Hospital, 588 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.

Max Ferguson (M)

British Columbia Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.

Alissa Greer (A)

School of Criminology, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.

Jackson Loyal (J)

British Columbia Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.
Centre for Applied Research in Mental Health and Addiction, Simon Fraser University, 2400 515 W Hastings St, Vancouver, BC, V6B 5K3, Canada.

Zahra Mamdani (Z)

British Columbia Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.

Heather Palis (H)

British Columbia Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.
Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada.

Bernie Pauly (B)

Canadian Institute for Substance Use Research, STN CSC, University of Victoria, Box 1700, Victoria, BC, Canada.

Amanda Slaunwhite (A)

School of Population and Public Health, University of British Columbia, 2206 E Mall, Vancouver, BC, V6T 1Z8, Canada.
British Columbia Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada.

Jane A Buxton (JA)

School of Population and Public Health, University of British Columbia, 2206 E Mall, Vancouver, BC, V6T 1Z8, Canada. jane.buxton@bccdc.ca.
British Columbia Centre for Disease Control, 655 W 12th Ave, Vancouver, BC, V5Z 4R4, Canada. jane.buxton@bccdc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH